Disease-modifying treatments in Alzheimer's disease

 

Welcome to the BIDMC DiAD clinic!

To refer a patient to our clinic for consideration of disease-modifying treatments, please fill out patient information below.


We will be offering novel treatments following the FDA and our pharmacy's appropirate use criteria, which include but are not limited to:

  • A diagnosis of MCI or mild dementia due to Alzhiemer's disease, corresponding to an approx MMSE > 20

We are not able to offer treatment at this time for patients with:

  • Active treatment with anticoagulation
  • APOE4/4 genotype
 
 
 
 
mm/dd/yyyy